🇺🇸 FDA
Patent

US 6677309

Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity compounds, compositions and methods

expired A61PA61P35/00A61P43/00

Quick answer

US patent 6677309 (Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity compounds, compositions and methods) held by The Regents of the University of Technology Office of Technology Transfer expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Technology Office of Technology Transfer
Grant date
Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
49
CPC classes
A61P, A61P35/00, A61P43/00